Back
Adverum Biotechnologies Quote, Financials, Valuation and Earnings
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
44
ADVM
Adverum Biotechnologies
Last Price:
6.88
Seasonality Move:
18.32%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Adverum Biotechnologies Price Quote
$6.88
-0.37 (-5.1%)
(Updated: November 15, 2024 at 4:20 PM ET)
Adverum Biotechnologies Key Stats
Sell
44
Adverum Biotechnologies (ADVM)
is a Sell
Day range:
$7.23 - $7.64
52-week range:
$6.38 - $29.70
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.05%
Volume:
204.4K
Avg. volume:
173.8K
1-year change:
-15.81%
Market cap:
$150.8M
Revenue:
$3.6M
EPS:
$-6.01
How Much Does Adverum Biotechnologies Make?
Data Unavailable
Is Adverum Biotechnologies Growing As A Company?
Data Unavailable
Adverum Biotechnologies Stock Price Performance
-
Did Adverum Biotechnologies Stock Go Up Last Month?
Adverum Biotechnologies share price went down by -6.21% last month -
Did ADVM's Share Price Rise Over The Last Year?
ADVM share price fell by -15.81% over the past 1 year
What Is Adverum Biotechnologies 52-Week High & Low?
-
What Is Adverum Biotechnologies’s 52-Week High Share Price?
Adverum Biotechnologies has traded as high as $29.70 over the past 52 weeks -
What Is Adverum Biotechnologies’s 52-Week Low Share Price?
Adverum Biotechnologies has traded as low as $6.38 over the past 52 weeks
Adverum Biotechnologies Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Adverum Biotechnologies?
-
How Much Debt Does Adverum Biotechnologies Have?
Total long term debt quarterly is $0 -
How Much Cash Does Adverum Biotechnologies Have?
Cash and short term investments quarterly total is $153.2M -
What Is Adverum Biotechnologies’s Book Value Per Share?
Book value per share is 6.93
Is Adverum Biotechnologies Cash Flow Positive?
-
What Is ADVM Cash Flow From Operations?
Cash flow from operations (TTM) is -$85.5M -
What Is Adverum Biotechnologies’s Cash Flow From Financing?
Cash flow from financing (TTM) is $119.9M -
What Is Adverum Biotechnologies’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$47.6M
Adverum Biotechnologies Return On Invested Capital
-
Is Management Doing A Good Job?
ADVM return on invested capital is -69.14% -
What Is Adverum Biotechnologies Return On Assets?
ROA measures how assets are converting to revenues and is -41.8% -
What Is ADVM Return On Equity?
ROE is a measure of profitability and is -69.14%
Adverum Biotechnologies Earnings Date & Stock Price
-
What Is Adverum Biotechnologies's Stock Price Today?
A single share of ADVM can be purchased today for 7.25 -
What Is Adverum Biotechnologies’s Stock Symbol?
Adverum Biotechnologies trades on the nasdaq under the ticker symbol: ADVM -
When Is Adverum Biotechnologies’s Next Earnings Date?
The next quarterly earnings date for Adverum Biotechnologies is scheduled on March 18, 2025 -
When Is ADVM's next ex-dividend date?
Adverum Biotechnologies's next ex-dividend date is November 15, 2024 -
How To Buy Adverum Biotechnologies Stock?
You can buy Adverum Biotechnologies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Adverum Biotechnologies Competitors
-
Who Are Adverum Biotechnologies's Competitors?
Below is a list of companies who compete with Adverum Biotechnologies or are related in some way:
Adverum Biotechnologies Dividend Yield
-
What Is ADVM Dividend Yield?
Adverum Biotechnologies’s dividend yield currently is 0% -
What Is Adverum Biotechnologies’s Payout Ratio?
Adverum Biotechnologies’s payout ratio is 0% -
When Did Adverum Biotechnologies Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Adverum Biotechnologies’s Dividend Per Share?
Adverum Biotechnologies pays a dividend of $0.00 per share
Adverum Biotechnologies Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0.13% |
| Revenue: | 0% | 1500% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 29.71 |
| Upside from Last Price: | 309.85% |